Article

Disability in Inflammatory Bowel Diseases: Developing ICF Core Sets for Patients with Inflammatory Bowel Diseases Based on the International Classification of Functioning, Disability, and Health

Department of Hepatogastroenterology, Claude Huriez Hospital, Centre Hospitalier Universitaire de Lille, Lille, France.
Inflammatory Bowel Diseases (Impact Factor: 5.48). 01/2010; 16(1):15-22. DOI: 10.1002/ibd.21010
Source: PubMed

ABSTRACT The inflammatory bowel diseases (IBDs) are associated with a reduced quality of life. The impact of IBD on disability remains largely unknown. With the International Classification of Functioning, Disability, and Health (ICF) of the World Health Organization (WHO), we can now rely on a globally agreed-upon framework and system for classifying the typical spectrum of problems in the functioning of persons with a specific disease given the environmental context in which they live. The aim of this article is to outline the methods to be utilized to develop ICF Core Sets for IBD. The project is a cooperation between the ICF Research Branch of the WHO, the IPNIC group, the International Society of Physical Rehabilitation Medicine (ISPRM), and the International Organization on Inflammatory Bowel Disease (IOIBD). Four worldwide studies will be conducted from 2009 to 2010. ICF categories relevant for IBD will be identified by systematic literature review of outcomes and measures used in IBD research, semistructured patient interviews, Internet-based expert survey, and cross-sectional study for clinical applicability. The final definition of ICF Core Sets for IBD will be determined at a Consensus Conference. Field testing will then be used to validate the ICF Core Sets. ICF Core Sets are being designed to provide useful standards for research and clinical practice. This tool will enable research that improves understanding of functioning, disability, and health in IBD, and may lead to interventions to improve and maintain functioning and minimize disability among IBD patients throughout the world.

Download full-text

Full-text

Available from: William J Sandborn, Jul 05, 2015
0 Followers
 · 
99 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: This paper proposes an innovative current control strategy for permanent magnet synchronous motor (PMSM) drives with both isotropic and anisotropic rotors, based on Pontryagin's time optimal control (TOC) theory. The control strategy assures the fastest current response after any demanded torque reference variation. It can be demonstrated that such a control exhibits faster response than hysteresis control, even if the latter is often considered the fastest control scheme. The theoretical principle of TOC is at first illustrated. It is then applied to PMSM drives and verified by simulations. Comparison to other control strategies is included in the paper. At last, an experimental validation is carried out and measured results are presented and discussed.
    IECON 02 [Industrial Electronics Society, IEEE 2002 28th Annual Conference of the]; 12/2002
  • Value in Health 11/2006; 9(6). DOI:10.1016/S1098-3015(10)63727-8 · 2.89 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Natural history studies provide invaluable data on the disease course. First, they help define the end points for clinical trials that are designed to test drugs for the end point of disease modification in chronic disabling diseases. Natural history studies can also help to identify subsets of patients in whom the disease prognosis can be stratified according to clinical features. This comprehensive review summarizes our current knowledge of the natural history of Crohn's disease in adults as reported in population-based studies that include long-term follow-up results. We conducted a literature search of English and non-English language publications listed in the electronic databases of MEDLINE (source PUBMED, 1935 to December 2008). One-third of the patients had ileitis, colitis, or ileocolitis at the time of diagnosis. Disease location remained broadly stable over time. Up to one-third of the patients had evidence of a stricturing or penetrating intestinal complication at diagnosis, and half of all patients had experienced an intestinal complication within 20 years after diagnosis. Ten percent of the patients had prolonged clinical remission. Steroid dependency occurred in one-third of the patients, and surgery was required in one-third after initiation of steroid therapy. The annual incidence of hospitalizations was 20%. Half of the patients required surgery within 10 years after diagnosis. The risk of postoperative recurrence was 44-55% after 10 years. Crohn's disease is a disabling condition over time. The impact of changing treatment paradigms with increased use of immunosuppressants and biological agents on its natural history is poorly known.
    The American Journal of Gastroenterology 10/2009; 105(2):289-97. DOI:10.1038/ajg.2009.579 · 9.21 Impact Factor